Ashley Margol - Concepedia

Author

Ashley Margol

Children's Hospital of Los Angeles ORCID

Also Known As

A. Margol, Ashley S. Margol, Ashley Margol, Ashley S Margol, Ashley S. Margol, Ashley Sloane Margol, Janis Yee, Margol, Ashley S, Margol, Ashley S., ashley margol

175

Publications

Citations

H-Index

Concepts

All Affiliations

Children's Hospital of Los Angeles University of Southern California Children's Hospital of Philadelphia Children's National University of Colorado Denver

About

Ashley Margol is an author at Children's Hospital of Los Angeles specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	701
2	Health Sciences	4	4	76
3	Cell Biology	3	3	115
4	Allergy	1	1	43
5	Family Medicine	1	1	49

Ashley Margol

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome Pooja Panwalkar, Jonathan R. Clark, Vijay Ramaswamy, Acta Neuropathologica Neuro-oncologyGlobal ReductionPowerful PredictorAutoimmune DiseaseHistopathology	2017	229
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas Jill Bayliss, Piali Mukherjee, Chao Lü, Science Translational Medicine	2016	187
Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High‐Dose Chemotherapy Lucie Lafay‐Cousin, Amy Smith, Elizabeth Wells, Pediatric Blood & Cancer	2016	124
Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas Ashley Margol, Nathan Robison, Janahan Gnanachandran, Clinical Cancer Research	2014	114
Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy Stefan Blüml, Ashley Margol, Richard Sposto, Neuro-Oncology	2015	83
Achieving Target Voriconazole Concentrations More Accurately in Children and Adolescents Michael Neely, Ashley Margol, Xiaowei Fu, Antimicrobial Agents and Chemotherapy	2015	67
Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells Daofeng Liu, Liping Song, Vita S. Brawley, Clinical Immunology Tumor ImmunologyCancer ImmunosurveillanceImmunologyImmune Checkpoint InhibitorAutoimmunity	2013	64
Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy Stephanie Toll, Tran N. Hung, Jennifer Cotter, Oncotarget	2019	60
Pediatric Brain Tumor Cell Lines Jingying Xu, Ashley Margol, Shahab Asgharzadeh, Journal of Cellular Biochemistry Pediatric Brain TumorsTumor InnervationPathologyHigh-grade GliomasGlioma	2014	59
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma Tom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, Neuro-Oncology	2022	56

Page 1